Inactive Instrument

Press Releases Cesca Therapeutics Inc Nasdaq

Equities

US1571311034

Press Releases

Unlock all the news: Be the first to know and act before the market!

ThermoGenesis : Material Event - Form 8-K	03-20	PU
ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update	11-13	PR
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update	11-08	PR
ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento	26/10/23	PR
ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference	06/09/23	PR
ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update	10/08/23	PR
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update	08/08/23	PR
ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu	17/07/23	PR
ThermoGenesis : Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu	17/07/23	PU
ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate Update	15/05/23	PR
ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic Update	10/05/23	PR
THERMOGENESIS HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	30/03/23	AQ
THERMOGENESIS HOLDINGS, INC. : Results of Operations and Financial Condition (form 8-K)	30/03/23	AQ
ThermoGenesis Holdings Announces Year End 2022 Financial Results and Provides Corporate Update	30/03/23	PR
ThermoGenesis Holdings to Announce Financial Results for the Year Ended December 31, 2022 and Provide a Corporate Strategic Update	28/03/23	PR
THERMOGENESIS HOLDINGS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	21/03/23	AQ
THERMOGENESIS CLOSES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES	20/03/23	PR
THERMOGENESIS ANNOUNCES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES	16/03/23	PR
ThermoGenesis Announces Roll Out of ReadyStart cGMP Suites for Early-Stage Cell and Gene Therapy Companies	15/03/23	PR
ThermoGenesis : Material Agreement - Form 8-K	10/03/23	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Cesca Therapeutics Inc Nasdaq

Equities

US1571311034

Press Releases

Filters